EMERAM Capital Partners GmbH-backed Meona GmbH purchased Dr. Heni SOFTWARE GmbH & Co. KG for an undisclosed amount.
Dr. Heni Software, through its software products ZENZY and A-Taxe, supports hospitals and pharmacies in the production and billing of medicines and cytostatics drugs, which are natural or synthetic substances that inhibit cell growth or cell division.
Meona has been a portfolio company of EMERAM since 2017. EMERAM is a private investment firm focused on medium-sized businesses in German-speaking countries in the sectors of consumer goods, retail, industrial goods, business services and healthcare.
Dr. Heni Software founder Josef Heni was advised by Dr. Heni und Partner Steuerberater Rechtsanwälte PartGmbB, while Meona was advised by Friedrich Graf von Westphalen. Tax advice was provided by Melzer und Kollegen.